Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun 25;22(13):6839.
doi: 10.3390/ijms22136839.

RETRACTED: Thymoquinone and Curcumin Defeat Aging-Associated Oxidative Alterations Induced by D-Galactose in Rats' Brain and Heart

Affiliations

RETRACTED: Thymoquinone and Curcumin Defeat Aging-Associated Oxidative Alterations Induced by D-Galactose in Rats' Brain and Heart

Ali H El-Far et al. Int J Mol Sci. .

Retraction in

Abstract

D-galactose (D-gal) administration causes oxidative disorder and is widely utilized in aging animal models. Therefore, we subcutaneously injected D-gal at 200 mg/kg BW dose to assess the potential preventive effect of thymoquinone (TQ) and curcumin (Cur) against the oxidative alterations induced by D-gal. Other than the control, vehicle, and D-gal groups, the TQ and Cur treated groups were orally supplemented at 20 mg/kg BW of each alone or combined. TQ and Cur effectively suppressed the oxidative alterations induced by D-gal in brain and heart tissues. The TQ and Cur combination significantly decreased the elevated necrosis in the brain and heart by D-gal. It significantly reduced brain caspase 3, calbindin, and calcium-binding adapter molecule 1 (IBA1), heart caspase 3, and BCL2. Expression of mRNA of the brain and heart TP53, p21, Bax, and CASP-3 were significantly downregulated in the TQ and Cur combination group along with upregulation of BCL2 in comparison with the D-gal group. Data suggested that the TQ and Cur combination is a promising approach in aging prevention.

Keywords: D-galactose; anti-aging; curcumin; oxidative stress; thymoquinone.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Chemical Structure. (A) thymoquinone (PubChem CID; 10281). (B) curcumin (PubChem CID; 969516).
Figure 2
Figure 2
Serum biochemical parameters. (A) glucose (mg/dL). (B) ALT (U/L). (C) AST (U/L). (D) urea (mg/dL). (E) creatinine (mg/dL). (F) uric acid (mg/dL). Data were analyzed with one-way ANOVA, followed by Tukey’s multiple comparison test. * p < 0.05, ** p < 0.01, and *** p < 0.001 vs. control. + p < 0.05, ++ p < 0.01, and +++ p < 0.001 vs. vehicle. x p < 0.05 and xx p < 0.01 vs. D-gal. ɸɸɸ p < 0.001 vs. D-gal+TQ. ## p < 0.01 vs. D-gal+TQ+Cur. Error bars represent mean ± SD. n = 5.
Figure 3
Figure 3
Immunohistochemical staining of rat cerebellum by caspase 3. (A) negative control group. (B) vehicle group. (C) D-gal group revealing strong caspase 3 reaction in Purkinje cells layer (PCL), in granular cells layer (GL) and in molecular cells layer (ML). (D) D-gal+TQ group. (E) D-gal+Cur group. (F) D-gal+TQ+Cur group. (G) Quantification of caspase 3 in the cerebellum in different groups. Scale bar = 50 µm. Data were analyzed with one-way ANOVA, followed by Tukey’s multiple comparison test. *** p < 0.001 vs. control. ++ p < 0.01 and +++ p < 0.001 vs. vehicle. xxx p < 0.001 vs. D-gal. ɸɸɸ p < 0.001 vs. D-gal+TQ. ### p < 0.001 vs. D-gal+TQ+Cur. Error bars represent mean ± SD. n = 10.
Figure 4
Figure 4
Immunohistochemical staining of rat cerebellum by calbindin. (A) negative control group showing high reaction in calbindin in many Purkinje cells (arrow). (B) vehicle group. (C) D-gal group revealing no calbindin reaction in necrotic Purkinje cells (arrowhead). (D) D-gal+TQ group. (E) D-gal+Cur group. (F) D-gal+TQ+Cur group. (G) Quantification of positive Purkinje cells in different groups. Scale bar = 50 µm. Data were analyzed with one-way ANOVA, followed by Tukey’s multiple comparison test. *** p < 0.001 vs. control. +++ p < 0.001 vs. vehicle. xxx p < 0.001 vs. D-gal. ɸ p < 0.05 vs. D-gal+TQ. ### p < 0.001 vs. D-gal+TQ+Cur. Error bars represent mean ± SD. n = 10.
Figure 5
Figure 5
Immunohistochemical staining of rat cerebellum by ionized calcium-binding adapter molecule 1 (IBA1). (A) negative control group showed few microglia. (B) vehicle group. (C) D-Gal group showed many positive microglia. (D) D-gal+TQ group. (E) D-gal+Cur group. (F) D-gal+TQ+Cur group. (G) Quantification of IBA1 in the cerebellum in different groups. Scale bar = 50 µm. Data were analyzed with one-way ANOVA, followed by Tukey’s multiple comparison test. ** p < 0.01 and *** p < 0.001 vs. control. + p < 0.05 and +++ p < 0.001 vs. vehicle. xxx p < 0.001 vs. D-gal. ɸɸɸ p < 0.001 vs. D-gal+TQ. ### p < 0.001 vs. D-gal+TQ+Cur. Error bars represent mean ± SD. n = 10.
Figure 6
Figure 6
Immunohistochemical staining of rat hippocampus by caspase 3. (A) negative control group. (B) vehicle group. (C) D-gal group revealing strong caspase 3 reaction. (D) D-gal+TQ group. (E) D-gal+Cur group. (F) D-gal+TQ+Cur group. (G) Quantification of caspase 3 in the hippocampus in different groups. Scale bar = 50 µm. Data were analyzed with one-way ANOVA, followed by Tukey’s multiple comparison test. *** p < 0.001 vs. control. +++ p < 0.001 vs. vehicle. xxx p < 0.001 vs. D-gal. ɸɸɸ p < 0.001 vs. D-gal+TQ. ### p < 0.001 vs. D-gal+TQ+Cur. Error bars represent mean ± SD. n = 10.
Figure 7
Figure 7
Immunohistochemical staining of rat hippocampus by calbindin. (A) negative control group showing the high reaction of calbindin. (B) vehicle group. (C) D-gal group showed many positive microglia. (D) D-gal+TQ group. (E) D-gal+Cur group. (F) D-gal+TQ+Cur group. (G) Quantification of positive cells in different groups. Scale bar = 50 µm. Data were analyzed with one-way ANOVA, followed by Tukey’s multiple comparison test. *** p < 0.001 vs. control. +++ p < 0.001 vs. vehicle. xxx p < 0.001 vs. D-gal. ### p < 0.001 vs. D-gal+TQ+Cur. Error bars represent mean ± SD. n = 10.
Figure 8
Figure 8
Immunohistochemical staining of rat hippocampus by ionized calcium-binding adapter molecule 1 (IBA1). (A) the negative control group showed few microglia. (B) vehicle group. (C) D-gal group showed many positive microglia. (D) D-gal+TQ group. (E) D-gal+Cur group. (F) D-gal+TQ+Cur group. (G) Quantification of IBA1 in the hippocampus in different groups. Scale bar = 50 µm. Data were analyzed with one-way ANOVA, followed by Tukey’s multiple comparison test. *** p < 0.001 vs. control. +++ p < 0.001 vs. vehicle. xxx p < 0.001 vs. D-gal. ɸɸɸ p < 0.001 vs. D-gal+TQ. ### p < 0.001 vs. D-gal+TQ+Cur. Error bars represent mean ± SD. n = 10.
Figure 9
Figure 9
Immunohistochemical staining of rat heart by Bcl2. (A) negative control group. (B) vehicle group. (C) D-gal group. (D) D-gal+TQ group. (E) D-gal+Cur group. (F) D-gal+TQ+Cur group. (G) Quantification of Bcl2 in different groups. Scale bar = 50 µm. Data were analyzed with one-way ANOVA, followed by Tukey’s multiple comparison test. *** p < 0.001 vs. control. +++ p < 0.001 vs. vehicle. xxx p < 0.001 vs. D-gal. ɸɸɸ p < 0.001 vs. D-gal+TQ. ### p < 0.001 vs. D-gal+TQ+Cur. Error bars represent mean ± SD. n = 10.
Figure 10
Figure 10
Immunohistochemical staining of rat heart by caspase 3. (A) negative control group. (B) vehicle group. (C) D-gal group revealing strong caspase 3 reaction in nuclei. (D) D-gal+TQ group. (E) D-gal+Cur group. (F) D-gal+TQ+Cur group. (G) Quantification of caspase 3 in the heart in different groups. Scale bar = 50 µm. Data were analyzed with one-way ANOVA, followed by Tukey’s multiple comparison test. *** p < 0.001 vs. control. +++ p < 0.001 vs. vehicle. xx p < 0.01 and xxx p < 0.001 vs. D-gal. ### p < 0.001 vs. D-gal+TQ+Cur. Error bars represent mean ± SD. n = 10.
Figure 11
Figure 11
Expression of fold changes of brain (A) TP53, (B) p21, (C) BCL2, (D) Bax, and (E) CASP-3. Data were analyzed with one-way ANOVA, followed by Tukey’s multiple comparison test. * p < 0.05, ** p < 0.01, and *** p < 0.001 vs. control. + p < 0.05, ++ p < 0.01, and +++ p < 0.001 vs. vehicle. xxx p < 0.001 vs. D-gal. # p < 0.05 vs. D-gal+TQ+Cur. Error bars represent mean ± SD. n = 5.
Figure 12
Figure 12
Expression of fold changes of heart (A) TP53, (B) p21, (C) BCL2, (D) Bax, and (E) CASP-3. Data were analyzed with one-way ANOVA, followed by Tukey’s multiple comparison test. * p < 0.05 and *** p < 0.001 vs. control. ++ p < 0.01 and +++ p < 0.001 vs. vehicle. x p < 0.05, xx p < 0.01, and xxx p < 0.001 vs. D-gal. ## p < 0.01 vs. D-gal+TQ+Cur. Error bars represent mean ± SD. n = 5.
Figure 13
Figure 13
Experimental design scheme. D-gal; D-galactose, S/C; subcutaneous, TQ; thymoquinone, Cur; curcumin, B.W.; body weight.

Similar articles

Cited by

References

    1. Chen W.K., Tsai Y.L., Shibu M.A., Shen C.Y., Chang-Lee S.N., Chen R.J., Yao C.H., Ban B., Kuo W.W., Huang C.Y. Exercise training augments Sirt1-signaling and attenuates cardiac inflammation in D-galactose induced-aging rats. Aging. 2018;10:4166–4174. doi: 10.18632/aging.101714. - DOI - PMC - PubMed
    1. Davalli P., Mitic T., Caporali A., Lauriola A., D’Arca D. ROS, Cell Senescence, and Novel Molecular Mechanisms in Aging and Age-Related Diseases. Oxid. Med. Cell. Longev. 2016;2016:1–18. doi: 10.1155/2016/3565127. - DOI - PMC - PubMed
    1. Zhao F., Zhou Y., Gao L., Qin X., Du G. [Advances in the study of the rat model of aging induced by D-galactose] Yao Xue Xue Bao. 2017;52:347–354. - PubMed
    1. Hegab Z. Role of advanced glycation end products in cardiovascular disease. World J. Cardiol. 2012;4:90. doi: 10.4330/wjc.v4.i4.90. - DOI - PMC - PubMed
    1. Frimat M., Daroux M., Litke R., Nevière R., Tessier F.J., Boulanger E. Kidney, heart and brain: Three organs targeted by ageing and glycation. Clin. Sci. 2017;131:1069–1092. doi: 10.1042/CS20160823. - DOI - PubMed

Publication types